Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.52 USD | +1.36% |
|
-4.16% | +69.06% |
01/07 | Y-mAbs Therapeutics Appoints Peter Pfreundschuh as CFO | MT |
01/07 | Y-mAbs Therapeutics, Inc. Announces the Appointment of Peter Pfreundschuh as Chief Financial Officer | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.06% | 499M | |
+15.55% | 122B | |
+17.58% | 113B | |
+17.29% | 26.22B | |
-23.33% | 19.01B | |
-19.49% | 15.71B | |
-17.95% | 15.22B | |
-47.37% | 14.72B | |
+59.86% | 14.58B | |
+5.01% | 13.84B |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- Transcript : Y-mAbs Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 02